AQR Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,005
Closed -$286K 2392
2023
Q2
$286K Buy
12,005
+1,634
+16% +$38.9K ﹤0.01% 1959
2023
Q1
$264K Buy
10,371
+2,968
+40% +$75.5K ﹤0.01% 1977
2022
Q4
$216K Buy
+7,403
New +$216K ﹤0.01% 2062